Vesper Bio Reports Positive Topline Results for VES001 in Frontotemporal Degeneration Phase Ib/IIa Trial
Positive Results for VES001 in Frontotemporal Degeneration Study A recent Phase Ib/IIa clinical trial has shown promising results for VES001, the first oral treatment being evaluated for frontotemporal degeneration (FTD). This study revealed that...
Read More